Acute tubulointerstitial nephritis and polyclonal hypergammaglobulinaemia: Which is the culprit?
Autor: | Isabel Millán, R. Enríquez, Luis Jiménez del Cerro, Tania Muci, Rosalía Ruiz-Ferrús, Sirvent Ae, Francisco Javier Ardoy-Ibañez, Amadeo Almiñana |
---|---|
Rok vydání: | 2018 |
Předmět: |
Systemic disease
medicine.medical_specialty Renal failure 030232 urology & nephrology Renal function Case Report 030204 cardiovascular system & hematology Gastroenterology Culprit 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Internal medicine medicine Acute tubulointerstitial nephritis Omeprazole Creatinine lcsh:R5-920 medicine.diagnostic_test business.industry General Medicine medicine.disease chemistry Immunohistochemistry Renal biopsy Hypergammaglobulinaemia business lcsh:Medicine (General) medicine.drug |
Zdroj: | Clinics and Practice Clinics and Practice, Vol 8, Iss 4 (2018) |
ISSN: | 2039-7275 |
Popis: | Proton pump inhibitors (PPIs) are among the most frequent implicated drugs in acute tubulointerstitial nephritis (ATIN), nevertheless it is important to report cases with atypical profiles. A 80-year-old female, exposed during 34 months to omeprazole, presented with polyclonal hypergammaglobulinaemia and renal failure. After stopping omeprazole there was a partial improvement in serum creatinine and IgG. Renal biopsy revealed ATIN; immunohistochemistry for IgG4 was negative. Treatment with steroids and mycophenolate sodium improved renal function and normalized immunoglobulins. The lack of data of other entities and the patient’s evolution strongly point omeprazole as the culprit. After 27 months of follow-up, she remains clinical and analytically stable. ATIN caused by PPIs may appear after a long period of exposure and may be accompanied by analytical anomalies that simulate a systemic disease. |
Databáze: | OpenAIRE |
Externí odkaz: |